London 27th March 2020:
At least 30 companies and
academic institutions, biotech startups and
large pharmaceutical companies such as Johnson & Johnson and
Sanofi on vaccines. Scientists have
already examined the entire genome of the virus and
found the proteins that made the infection
cause.
We believe that a number of
Biotech companies, including Gilead Sciences and
Moderna, in developing potential
Vaccines have made progress. Other
Biotech companies that use AI diagnostics
are also good in our opinion
positioned. These companies include
Insilico Medicine Inc., Vir Biotechnology Inc. and
Atomwise Inc.
While the stock prices of these companies continue
in our opinion, should rise
other healthcare innovators, including
Telemedicine companies like CareClix and Babylon
Health already with the UK NHS
cooperate, as well as long-distance conference companies
how ZOOM can benefit from it.
The US biotech company Moderna
has the first production quantity of one last week
Human clinical vaccine
delivered. This is a quick one
Processing time after the researchers
January the genetic sequence of the virus
have decrypted. Moderna’s vaccine is said to be one
undergo study faster than expected
with the help of volunteers from the Seattle area.
The study is funded by the National Institute of Allergy
and Infectious Diseases of the United States Government
Sponsored. The vaccine will not come from
actual virus produced but contains
the RNA of the coronavirus that the body cells
instructs to make a protein from the virus.
This protein does not cause infection, it is said
however, a reaction of the immune system to that
Trigger virus. Such medical innovations,
including Rapid Response Platforms
among the best ways to get a vaccine
develop.
The speed at which this experimental
Vaccine developed by Moderna is a
Breakthrough for medical science. Of the
Vaccine was developed in 42 days after
the company genetic information about that
Corona virus had received. Moderna sent the
The vaccine was immediately sent to scientists from the
U.S. government. So there is still the possibility
to develop a vaccine before Christmas,
but mass production is likely
take another 4-6 months.
